Pages that link to "Q41606833"
Jump to navigation
Jump to search
The following pages link to Gene expression from adeno-associated virus vectors in airway epithelial cells (Q41606833):
Displaying 50 items.
- Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA (Q24562760) (← links)
- Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels (Q24646235) (← links)
- Adeno-associated viral vectors and their redirection to cell-type specific receptors (Q30885494) (← links)
- Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice (Q33305143) (← links)
- Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor (Q33783168) (← links)
- Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor (Q33908256) (← links)
- Adeno-associated virus as a gene delivery system (Q33933129) (← links)
- Adeno-associated virus vectors: activity and applications in the CNS. (Q33958498) (← links)
- Current status of gene therapy for cystic fibrosis pulmonary disease (Q33975113) (← links)
- Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein (Q34057580) (← links)
- Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor (Q34199152) (← links)
- DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors (Q34251868) (← links)
- Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo (Q34277742) (← links)
- Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors (Q34534285) (← links)
- Emerging new therapies for chemotherapy-resistant cancer using adenoviral vectors (Q34750374) (← links)
- Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate (Q34974247) (← links)
- Regulation of gene expression in adeno-associated virus vectors in the brain (Q34987187) (← links)
- Adeno-associated virus vectors preferentially transduce cells in S phase. (Q35754006) (← links)
- Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. (Q35833899) (← links)
- Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells (Q35837539) (← links)
- Recombinant adeno-associated virus vectors for gene therapy (Q35842668) (← links)
- Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector (Q35872651) (← links)
- Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. (Q35889903) (← links)
- Adeno-associated virus vector integration junctions. (Q35898429) (← links)
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein (Q35943644) (← links)
- Adeno-associated virus-based gene therapy for inherited disorders (Q36321469) (← links)
- The Gordon Wilson Lecture. In vivo gene therapy: a strategy to use human genes as therapeutics (Q36647187) (← links)
- Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector (Q36663364) (← links)
- Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis (Q36712185) (← links)
- A small regulatory element from chromosome 19 enhances liver-specific gene expression (Q37148191) (← links)
- Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy (Q37316887) (← links)
- Novel strategy for generation and titration of recombinant adeno-associated virus vectors. (Q37747526) (← links)
- Sarcoplasmic reticulum and calcium cycling targeting by gene therapy (Q38016716) (← links)
- Molecular therapy for renal diseases (Q39182534) (← links)
- Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation (Q39581069) (← links)
- Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors. (Q39582021) (← links)
- Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element (Q39612405) (← links)
- Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome. (Q40154601) (← links)
- Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells (Q40370189) (← links)
- Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line (Q40521090) (← links)
- Gene therapy vectors as drug delivery systems (Q40530271) (← links)
- Prospects for virus-based gene therapy for cystic fibrosis (Q40851727) (← links)
- Strength and specificity of different gene promoters in oral cancer cells (Q40889999) (← links)
- Genetic therapy. Past, present, and future (Q40905745) (← links)
- Epithelial cell specific properties and genetic complementation in a delta F508 cystic fibrosis nasal polyp cell line (Q41300710) (← links)
- In Vivo Gene Therapy with Adeno-Associated Virus Vectors for Cystic Fibrosis (Q41526839) (← links)
- Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter (Q41573620) (← links)
- Adeno-associated virus type 2 p5 promoter: a rep-regulated DNA switch element functioning in transcription, replication, and site-specific integration (Q42797268) (← links)
- Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. (Q43567043) (← links)
- Aerosol Delivery of aβ-Galactosidase Adenoviral Vector to the Lungs of Rodents (Q43641517) (← links)